Clinical Trial Update: A Phase I Study of Continuous Intravenous Infusion of PSC 833 and Vinblastine in Patients With Metastatic Renal Cancer [Phase 1]

View source ↗

Summary

This Phase I study evaluated continuous intravenous infusion of PSC 833 (valspodar) with vinblastine in patients with metastatic renal cancer; the trial has bee…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• PSC 833 (valspodar)
• Vinblastine (vinblastine)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Kidney Neoplasms, Neoplasm Metastasis | Phase 1 | Status: COMPLETED